U.K. Supreme Court hands Eli Lilly big win in Alimta EU patent battle
admin 7th July 2017 Uncategorised 0The U.K. Supreme Court has handed Eli Lilly a huge patent victory for its cancer drug Alimta in a battle with Actavis, protecting some European sales of the blockbuster for another four years. It also represents a stunning loss for Actavis, now owned by Teva, which launched its generic several years ago at risk.
More: U.K. Supreme Court hands Eli Lilly big win in Alimta EU patent battle
Source: fierce